Pharmacology

Pharmacology News

Journal news

Pharmacology in Drug Discovery latest book now released

1510_20110282_468x60


622643Most Cited Paper Award for Vascular Pharmacology Announced

 We would like to congratulate the following authors of the winning papers:

Original articles:

Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: Underlying mechanisms
Mehrdad Roghani, Tourandokht Baluchnejadmojarad
Vascular Pharmacology 51 (2009) 84–89

Lycopus lucidus inhibits high glucose-induced vascular inflammation in human umbilical vein endothelial cells
Yun Jung Lee, Dae Gill Kang, Jin Sook Kim, Ho Sub Lee
Vascular Pharmacology 48 (2008) 38–46

Relaxant effects of danshen aqueous extract and its constituent danshensu on rat coronary artery are mediated by inhibition of calcium channels
Francis Fu Yuen Lam, John Hok Keung Yeung, Kam Ming Chan, Penelope Mei Yu Or
Vascular Pharmacology 46 (2007) 271–277

Review articles:

Angiogenesis and its targeting in rheumatoid arthritis
Zoltán Szekanecz, Alisa E. Koch
Vascular Pharmacology 51 (2009) 1–7

Endothelial nitric oxide (NO) and its pathophysiologic regulation
Anuran Chatterjee, John D. Catravas
Vascular Pharmacology 49 (2008) 134–140

Statins and the endothelium
Masaaki Ii, Douglas W. Losordo
Vascular Pharmacology 46 (2007) 1–9

For this year's award articles published in the years 2007, 2008 and 2009 were taken into account, with citations counted throughout 2010. Original research articles and review articles were evaluated as different categories. Data were generated using the Scopus database (www.scopus.com).



505776Eighth Annual Focused Issue on Methods in Safety Pharmacology Now Available

It is the eighth in a series, arising from the Annual Safety Pharmacology Society (SPS) meeting. The SPS is now in its 10th year as an independent branch of biological sciences (distinct from pharmacology and toxicology) and is the primary forum for driving advances in safety pharmacology. The theme of the meeting and this journal issue is innovation, and the focus is non-clinical safety assessment of new chemical entity (NCEs).  Read now

 


 

call_for_papers

525477Life Sciences : Special issue on cardiac dysfunction in diabetes
Submit Now
Deadline: February 1, 2012


Everything you need to know to publish a world class paper - Pharmacology author resources

 

 ask_the_editor_ani

651_ls_mini_reviews_468x58 



506087frans_nijkamp

New Editor-in-Chief

As of January 2010, Professor Frans Nijkamp is the new Editor-in-Chief of the European Journal of Pharmacology. He succeeds Professor Willem Hendrik Gispen, who has stepped down as the journal’s Editor-in-Chief after 15 years.  Read more






525477loren_woldLife Sciences mini-reviews by Loren Wold

Synthesis of the most innovative and progressive articles in any given scientific field is the goal of all review articles published in Life Sciences. While these articles are meant to provide a broad, yet in depth review of a chosen field, they are also excellent refresher articles for the experienced researcher, and teaching tools for the aspiring scientist.   Read more

 


525454mike_williamsBiochemical Pharmacology Commentaries by Mike Williams
Commentaries are a widely read and widely cited feature that appear in each issue of Biochemical Pharmacology. These brief, peer reviewed articles include timely updates on topics that include: molecular aspects of disease pathophysiology; targets of drug action; aspects of the teaching and current day role of pharmacology; and regulatory and policy issues related to drug discovery thus providing a forum for debate as it relates to understanding of issues and challenges to the study of the interrelated topics of
disease causality and drug discovery.   Read more


eye_catching_poster

ls_posterWant to have an eye-catching A2 (59.4 x 42 cm) poster with the first page of your article on the related journal cover? Check out on

http://webshop.elsevier.com/ to order your personal copy!

Conferences

Label-Free Technologies: Advances and Applications


Label-Free Technologies 
will be a two-day conference entirely dedicated to bringing together the latest research on the advances and application of label-free technology in pharmacology and drug discovery. Specifically aimed at providing unrivalled exposure of the most emerging practical applications, this is a chance for label-free users everywhere to glimpse the future of label-free applications and help shape the future of research in their field. 

The exciting programme will focus on three themes; state of the art, new applications of currently available instruments and emerging technologies.

For more information on this conference, visit www.labelfreetech.com